According to the Irdai data, up to September 2023 health insurance...
Category:
Health
Latest
Almost 400,000 deaths in Europe in 2021 attributable to filthy air -EU report
The European Environment Agency (EEA) said that within the European...
Climate change events may soon start affecting your brain functioning: Study
In the new study, teams from the universities of Geneva, New York,...
Heart inflammation probed as possible rare Covid vaccine side effect in teens, young adults
An article on seven U.S. teen boys in several states, published online Friday in Pediatrics, is among the latest reports of heart inflammation discovered after Covid-19 vaccination, though a link to the vaccine has not been proven.
Delta variant dominant in UK, may increase risk of hospitalisation
There were 5,472 new cases of the Delta variant reported in latest weekly figures, taking the total confirmed cases of the variant to 12,431, PHE said, adding it had overtaken Alpha, the variant first identified in England’s Kent, as Britain’s dominant variant.
The Delta variant is also thought to be more transmissible than Alpha, and Prime Minister Boris Johnson has warned that it could derail plans for lockdown restrictions in England to end on June 21.
No death reported in those infected with Covid-19 after vaccination, says AIIMS study
ACKO clocks Rs 100 crore from employee group health insurance premium in FY21
Over 70 companies including Virtusa, Swiggy, Razorpay, CRED, Akzo Nobel, Xiaomi, RedFM, ICRA, Grofers, Mygate and Go-MMT offer ACKO’s digital health benefits, it said.
Headache most common health ailment among urban Indians: Survey
“Notably for fever, consumers chose doctor visit over self-medication whereas for headache, cough and cold, more respondents seemed to self-medicate and rely on chemists. Further, gastric conditions were found to be more prevalent among geriatrics.
“Interestingly, Eno has emerged the top OTC brand choice for gastric conditions with at least 7 in 10 urban Indian preferring it. Zandu Balm was the top choice among balms for headaches,” says a statement by Ipsos.
India’s daily new COVID-19 cases decline to 1.32 lakhs, fatalities at 2,713
India’s active caseload further declined to 16,35,993 as active cases decreased by 77,420 in the last 24 hours. The active cases in the country have been less than 2 lakhs since eight successive days. The daily positivity rate stands at 6.38 per cent, remaining below the 10 per cent-mark for 11 consecutive days, while the weekly positivity rate stands at 7.27 per cent.
Pre-Covid level normalcy to return next year, touch 4 lakh passengers a day: Civil Aviation Minister Hardeep Puri
“When the second wave came and this passenger traffic came down to 40,000 last week. On Thursday it increased to 80,000 and later it will continue to increase with the decline in COVID cases,” said the Union Minister.
Children can’t be vaccinated currently, trials on below 18 underway: Centre to Delhi HC
The Centre submitted affidavits saying, “The Companies manufacturing COVID-19 vaccination in India have given only “Emergency Use Authorization for vaccinating people of 18 years age and above, therefore, COVID vaccines are not recommended for persons/children less than 18 years of age. This is also because of the fact that the clinical trial group during phase 1, phase 2 and phase 3 did not cover the children below 18 years of age.”
“Epidemiologists have made very clear the third wave of COVID-19 is inevitable in India”
Third wave of COVID-19 is inevitable and is likely to start from September-October, so the country should vaccinate as many people as possible.
”But in the second wave, the virus had a different characteristic which resulted in an indirect attack on lungs in a big way, which resulted in a large number of people demanding oxygen at a very early stage of infection.
Indian panel says global response needed to contain more infectious virus variant
Dubbed the “delta variant” by the World Health Organization, it is estimated to be 50% more transmissible than the coronavirus variant first found in Britain, researchers at the Indian SARS-CoV-2 Genetics Consortium and the National Centre for Disease Control said.